Medline Industries’ $167.5 Million Acquisition of AngioDynamics NAMIC Fluid Management Business

Cadwalader is advising AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for oncology, vascular access, and peripheral vascular disease, on its definitive agreement to sell its NAMIC® fluid management portfolio to Medline Industries, Inc. for $167.5 million.

The transaction is subject to customary closing conditions, including antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

The transaction consists of AngioDynamics’ NAMIC brand and its extensive offering of manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories. Additionally, AngioDynamics’ primary Glens Falls, New York manufacturing facility, including all related manufacturing jobs and the sales and marketing teams that support the NAMIC business, will be acquired by Medline as part of the transaction.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products.

Medline is a manufacturer, distributor and solutions provider focused on improving the overall operating performance of healthcare. Medline works with both the country’s largest healthcare systems and independent facilities across the continuum of care to provide the clinical and supply chain resources required for long-term financial viability in delivering high quality care. Headquartered in Northfield, Ill., Medline has 20,000+ employees worldwide and does business in more than 90 countries.

Cadwalader advised with a team including William Mills (Picture), Braden McCurrach Peter Bariso (M&A); Linda Swartz, Edward Wei (Tax), David Teigman, Nicholas LaSpina (Executive Compensation), Bill White (Environmental), Joel Mitnick and Ngoc Pham Hulbig (Antitrust).

Involved fees earner: Peter Bariso – Cadwalader Wickersham & Taft; Nicholas Laspina – Cadwalader Wickersham & Taft; Braden McCurrach – Cadwalader Wickersham & Taft; William Mills – Cadwalader Wickersham & Taft; Joel Mitnick – Cadwalader Wickersham & Taft; Ngoc Pham Hulbig – Cadwalader Wickersham & Taft; Linda Swartz – Cadwalader Wickersham & Taft; David Teigman – Cadwalader Wickersham & Taft; Edward Wei – Cadwalader Wickersham & Taft; Bill White – Cadwalader Wickersham & Taft;

Law Firms: Cadwalader Wickersham & Taft;

Clients: AngioDynamics Inc.;

Author: Ambrogio Visconti